ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Adia Nutrition Inc (PK)

Adia Nutrition Inc (PK) (ADIA)

0.076
-0.034
(-30.91%)
Closed February 13 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.076
Bid
0.076
Ask
0.095
Volume
541,098
0.076 Day's Range 0.125
0.0026 52 Week Range 0.172
Previous Close
0.11
Open
0.12
Last Trade
4699
@
0.076
Last Trade Time
Average Volume (3m)
314,692
Financial Volume
$ 54,442
VWAP
0.100614

ADIA Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.03168.88888888890.0450.1720.0456526850.10586814CS
40.0664691.6666666670.00960.1720.00963943070.06729608CS
120.06849000.00760.1720.0053146920.05185689CS
260.0641538.6554621850.01190.1720.00262317610.03363816CS
520.059347.0588235290.0170.1720.00262637320.02276932CS
1560.0666600.010.1720.0011399370.02933814CS
2600.06849000.00760.1720.0011218490.02654342CS

ADIA - Frequently Asked Questions (FAQ)

What is the current Adia Nutrition (PK) share price?
The current share price of Adia Nutrition (PK) is $ 0.076
What is the 1 year trading range for Adia Nutrition (PK) share price?
Adia Nutrition (PK) has traded in the range of $ 0.0026 to $ 0.172 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ELIQQElectriq Power Holdings Inc (CE)
$ 0.20
(19,999,900.00%)
100
SARMFSouthern Arc Minerals Inc (CE)
$ 0.02
(1,999,900.00%)
200
AUSAFAustralis Capital Inc (CE)
$ 0.0101
(1,009,900.00%)
54.85k
RQHTFReliq Health Technologies Inc (CE)
$ 0.01
(999,900.00%)
48.25k
AAGRAfrican Agriculture Holdings Inc (CE)
$ 0.008
(799,900.00%)
100
AELTFAdacel Technologies Ltd (CE)
$ 0.000001
(-100.00%)
150
ZTNOZoom Technologies Inc (CE)
$ 0.000001
(-99.98%)
400
EPAZDEpazz Inc
 1.00
(-99.96%)
215
EOSSEOS Inc (CE)
$ 0.000001
(-99.91%)
1
TIOGTingo Group Inc (CE)
$ 0.0001
(-99.67%)
192.81k
HMBLHUMBL Inc (PK)
$ 0.0005
(0.00%)
433.83M
RONNRonn Motor Group Inc (PK)
$ 0.0004
(33.33%)
333.35M
PSWWPrincipal Solar Inc (PK)
$ 0.0004
(100.00%)
330.54M
EMEDElectroMedical Technologies Inc (PK)
$ 0.0002
(0.00%)
203.46M
RDARRaadr Inc (PK)
$ 0.00055
(-21.43%)
193.18M

ADIA Discussion

View Posts
Jaguarjacket Jaguarjacket 3 hours ago
All I want for Valentines Day is more ADIA Shares!
πŸ‘οΈ0
gail gail 3 hours ago
well, it gives us the chance to load up.
πŸ‘οΈ0
samson8 samson8 3 hours ago
It was f'ed with to manipulate the price up to where it is.
πŸ‘οΈ0
i_like_bb_stock i_like_bb_stock 3 hours ago
They sure are f'ing with this
πŸ‘οΈ0
downdraft downdraft 4 hours ago
Several years back, my dentist spent less than a half hour pulling a tooth and implanting a new one all in the same session, for $5,000. Imagine how much a stem cell clinic can bring in daily. From one of those posts that I linked earlier today, the average cost for a stem cell procedure was $4,000, but the AHSCT treatment would likely be a lot higher. it won't take much to start raking in the cash, IMO.
πŸ‘οΈ0
i_like_bb_stock i_like_bb_stock 4 hours ago
added a few more someone is giving this away
πŸ‘οΈ0
gail gail 4 hours ago
grabbed some on this dip.
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 4 hours ago
Larry Powalisz β€’ ceo@adiamed.com
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 4 hours ago
Larry Powalisz CEO, Adia Nutrition 321-788-0850
πŸ‘οΈ0
BCNstocks BCNstocks 4 hours ago
"To facilitate this transition, we've engaged a specialized consultant to meticulously handle the AHCA registration paperwork, alongside a financial expert to review and submit our financial data," noted Dr. Kalpesh Barot, lead physician of AHSCT at Adia Med. "We are fully committed to surpassing the AHCA's stringent criteria."

On the significance of AHCA approval, Larry Powalisz added, "The AHCA plays a pivotal role in healthcare regulation in Florida, ensuring that facilities like ours adhere to the highest standards of medical practice. This approval will affirm our status as a trusted provider, significantly boosting investor confidence and attracting more partnerships."
https://www.newsfilecorp.com/release/240465/Adia-Med-Advances-Towards-AHCA-Registration-to-Expand-Insurance-Coverage-for-Stem-Cell-Therapies
$ADIA
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 5 hours ago
That's right, also "As far as Institutional investor and banker. Yes we have been in talks. I believe once we file our 15c211 and get closer to OTCQB more will come." Straight from the CEO! EXCITED!
😍 1
AyaStocks AyaStocks 6 hours ago
$ADIA is Up on the Breakout Boards and getting lots of buzz.

https://investorshub.advfn.com/boards/breakoutboards.aspx
https://investorshub.advfn.com/boards/tcloud.aspx
πŸ‘οΈ0
downdraft downdraft 6 hours ago
Today's news appears to much better than some might think. Note that today's news deals with applying to the State of Florida's Agency for Health Care Administration (AHCA). But the real meat and potatoes is located further down in the article, where the company states, in part...

"Moreover, Adia Med has been contacted by multiple potential clients who have already been preapproved by select private insurers for either HSCT therapy or injectable stem cell therapy. This development represents a seismic shift within the medical industry, where insurers seem to be broadening their scope of coverage to include non-traditional treatments."

So there are already customers waiting in line with their pre-approved insurance, which is really what's key!

My guess is that potential investors will be kicking themselves soon for not jumping in while they can. The application process with the State of Florida can likely be resolved by just following the rules that the Agency for Health Care Administration has in place. If there are upgrades they need to make to the facility or the protocols, that's fixable, but what we have in play already is insurance companies on board, just waiting for the final administrative approvals!
💥 1
AyaStocks AyaStocks 7 hours ago
$ADIA is the real deal!
πŸ‘οΈ0
gail gail 7 hours ago
lets see what she does.
πŸ‘οΈ0
downdraft downdraft 8 hours ago
I don't think the CEO would have dropped hundreds of thousands of dollars (that's my guess) to launch this business if he wasn't reassured/convinced in advance that he would be able to have insurance approved for this particular type of stem cell procedure for M.S., that has lots of successful results worldwide.

I think of it as a long term benefit to the state and the insurance companies, because if you have lots of young people who contract the disease and only use traditional drug methods to arrest it, and those same old relatively ineffective procedures don't work to halt the progression of the disease in most cases, then you're left with far greater expenses to the health care system and the insurers over the course of decades, not counting the misery that the patients have to endure for decades as they get progressively worse.

However, if this newer AHSCT method, that has proven to be quite effective around the world, manages to put the M.S. in remission for decades, that becomes a huge cost savings to the insurance agencies over time! That's why I think the likelihood of insurance approval is very high!
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 9 hours ago
Just email text or call, you will get an answer, and pretty quickly I might add! Larry Powalisz
CEO, Adia Nutrition
ADIA Nutrition Inc
ADIA Med
321-788-0850
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 9 hours ago
Extremely Busy times. I'm loving every minute of it. It's exciting to see your vision come to life.

Adia has had funding in place for almost a year now. No need for any other funders that could be toxic and hurt the company or our loyal shareholders.

As far as Institutional investor and banker. Yes we have been in talks. I believe once we file our 15c211 and get closer to OTCQB more will come.

Keep a lookout for more news and updates over the next days, weeks and months.

Thanks again for supporting Adia.

LOTS MORE TO COME!!

Thanks,

Don't have a good day, HAVE A GREAT ONE!

Larry Powalisz
CEO, Adia Nutrition
ADIA Nutrition Inc
ADIA Med
321-788-0850
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 9 hours ago
ADIA is A Beast! You are right, Let's Goooo!
πŸ‘οΈ0
samson8 samson8 9 hours ago
How exactly did this CEO get his money? Oh from running pump and dump OTC schemes in the past. What other successful businesses has he run?
πŸ‘οΈ0
gail gail 9 hours ago
inching up.
πŸ‘οΈ0
downdraft downdraft 9 hours ago
It boils down to this for me...

Not only do we have a CEO who is a walking testimonial for the success of this AHSCT for M.S., but he happens to be a well-funded businessman himself, having identified a great new business opportunity. He's motivated to succeed from both a health and business perspective.

For any new investors, you can see all the efforts he has put into the business via the company's X page at @ADIA_Nutrition. There is lot of information there to uncover.

Plus, if you read through a lot of articles on line, procedures aren't cheap in this industry. Even a basic procedure can cost several thousand dollars, up to tens of thousands of dollars. But what I really like is how he is trying to corner the market with his primary focus being on procedures for Multiple Sclerosis patients. It seems to be that one area, using the AHSCT process, that is quite well proven its value in many countries around the world. With the right medical team on board, along with the stem cell extracting and freezing equipment, it looks like ADIA is in a sweet spot to become the leader in this space! That's what I'm counting on.

Finally, who the heck would believe that all of this comes wrapped into an OTC company that has No Convertible Debt! Just keep repeating that! Oh, and a crazy good number outstanding shares. Yep, super sleeper beast stock from my perspective.
πŸ‘οΈ0
BCNstocks BCNstocks 9 hours ago
Nhod on deck! $ADIA
👍️ 1
downdraft downdraft 9 hours ago
And just last month, out of Europe, more positive opinions about the AHSCT procedure. In part...

"Conclusions

Immunological studies provide increasing support to the hypothesis that β€˜immune resetting’ is the mechanism of action of AHSCT in MS. Refinement of treatment protocols and patient selection has improved the efficacy and safety of the procedure. Uncontrolled cohort studies and meta-analyses have shown that among people with relapsing–remitting MS in whom standard treatment has failed, AHSCT has high effectiveness with acceptable safety, and two RCTs have shown that its efficacy is greater than that of moderate-efficacy and some high-efficacy DMTs (mitoxantrone and natalizumab).

Link to the article
πŸ‘οΈ0
downdraft downdraft 10 hours ago
Here's a link to the Abstract for a paper that gives the recommendation of the National Multiple Sclerosis Society, concerning AHSCT. In part, it states...

"Conclusions and relevance: The National Multiple Sclerosis Society believes that AHSCT may be a useful treatment option for people with relapsing multiple sclerosis who demonstrate substantial breakthrough disease activity (ie, new inflammatory central nervous system lesions and/or clinical relapses) despite treatment with high-efficacy disease-modifying therapy or have contraindications to high-efficacy disease-modifying therapies."

Link to Article
πŸ‘οΈ0
downdraft downdraft 10 hours ago
ADIA is a beast in disguise. This CEO is ultra-motivated to succeed as his own health is on the line. He knows the procedure works and has enough business savvy to pull it off from my perspective. Even the application for insurance in Florida is timed correctly as you have to have the doctors, facilities and protocols in place before you can even begin to get approval. Otherwise it would be like me trying to get insurance on a house that isn't built yet.

Here's a link to an overview article about the stem cell industry back in 2021, from the University of California. Even in here the author states, in part...

"Acknowledging that some
cell-based medical interventions such as
products falling within the same surgical
procedure exception and autologous,
minimally manipulated cellular products
used in a homologous manner do not
require premarketing review and licensure
by the FDA..."

Link to article with an overview of the stem cell market
πŸ‘οΈ0
BCNstocks BCNstocks 10 hours ago
Nice news!! Adia Med is in the process of AHCA registration to secure private insurance approval for its advanced stem cell therapies, including aHSCT & injectable stem cells. This will expand accessibility, affordability, & partnerships nationwide!

Adia Med Advances Towards AHCA Registration to Expand Insurance Coverage for Stem Cell Therapies
https://www.newsfilecorp.com/release/240465/Adia-Med-Advances-Towards-AHCA-Registration-to-Expand-Insurance-Coverage-for-Stem-Cell-Therapies
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 10 hours ago
ADIA First to Market with this Technique! Going Big Boards Soon! No more pennies, we Talking Dollars $$$$
👍️ 1 💯 2
downdraft downdraft 10 hours ago
The more I dig into this play, the stronger it looks! I'll provide several research links next hour, when I get back to my desk, that validates the information that the CEO has posted about.

Stem cell type businesses have been around for years, some operating on the edge of FDA approval. But ADIA's primary approach using aHSCT to help multiple sclerosis patients is indeed a key technique that doesn't require FDA approval. It made complete sense as I read through the articles.
πŸ‘οΈ0
SpaceManTrades SpaceManTrades 10 hours ago
This part from todays PR. 🔥


Until now, Adia Med's operations have depended solely on out-of-pocket payments from patients. However, the shift to accepting private insurance promises to transform patient care by:

✅️Increasing Affordability: By lowering the cost barrier, AHSCT and injectable stem cell treatments will be within reach for a broader demographic, significantly reducing the financial strain on individuals seeking these advanced medical solutions.

✅️Enhancing Accessibility: More patients will have the opportunity to benefit from these therapies without the immediate financial burden, fostering health equity.
Strengthening Partnerships: Developing robust relationships with insurance providers to integrate Adia Med's treatments into various health coverage plans.
👍️ 1
Jaguarjacket Jaguarjacket 10 hours ago
1st to market wins! ADIA WINNING!
πŸ‘οΈ0
i_like_bb_stock i_like_bb_stock 10 hours ago
Bids at .12 nice can break .17 today
πŸ‘οΈ0
AyaStocks AyaStocks 10 hours ago
$ADIA NEWS OUT! ~ Adia Med Advances Towards AHCA Registration to Expand Insurance Coverage for Stem Cell Therapies https://www.otcmarkets.com/stock/ADIA/news/story?e&id=3137570
πŸ‘οΈ0
samson8 samson8 11 hours ago
So, they PR'ed applying for something that will likely not ever get approved. Got it. If this is such a lucrative venture and completely on the up and up, why are they the only clinic in the US providing this outside of trials?
πŸ‘οΈ0
i_like_bb_stock i_like_bb_stock 11 hours ago
news https://www.otcmarkets.com/stock/ADIA/news/story?e&id=3137570
πŸ‘οΈ0
Juntao Juntao 11 hours ago
$ADIA https://www.newsfilecorp.com/release/240465
Adia Med Advances Towards AHCA Registration to Expand Insurance Coverage for Stem Cell Therapies
πŸ‘οΈ0
Juntao Juntao 13 hours ago
Morning $ADIA
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 20 hours ago
💎 🙌
👍️ 1
Spartanfan1 Spartanfan1 21 hours ago
Sure Jan 
πŸ‘οΈ0
samson8 samson8 22 hours ago
All pushed by share washing algorithms to give the appearance of volume.
πŸ‘οΈ0
Spartanfan1 Spartanfan1 22 hours ago
Nearly 2:1 buy to sells today 

Data is fun 
πŸ‘οΈ0
Rice Krispy Gang Rice Krispy Gang 23 hours ago
Who dumped this shitty stock?
πŸ‘οΈ0
samson8 samson8 1 day ago
This is your modern day snake oil salesman. Don't be the last one holding the bag
πŸ‘οΈ0
downdraft downdraft 1 day ago
Sweet! I suspect it will take another month before the larger investment community starts to see what's at play here.
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 1 day ago
Congrats on the smart investment and assessment.
πŸ‘οΈ0
i_like_bb_stock i_like_bb_stock 1 day ago
https://x.com/ADIA_Nutrition/status/1889759782548152827
πŸ‘οΈ0
downdraft downdraft 1 day ago
And even if they only charged $20,000 for each patient for the M.S. treatments, 20 patients per month would be $4.8 million in annual revenue for one clinic. Plus, they appear to be on a path to offer a variety of other treatments as well. I think a massive revenue business has just launched.

A bonus is that the walk-through video of the medical building indicates to me that it's not all that complicated to build out each location. There was a break room, a couple of bathrooms, doctor's offices, several patient rooms and the lab room they held the stem cell separation machine and the cryogenic unit for freezing the stem cells.

I loaded up more shares today on the expected pullback. I just couldn't get in at the very bottom as my bank doesn't open until 1.5 hours after the market opens so it was almost 2 hours after the market opened before I had a wire transfer go through.
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 1 day ago
ADIA has a lot more coming!
πŸ‘οΈ0
downdraft downdraft 1 day ago
Just because ADIA has had a huge run the past couple of weeks doesn't mean it's over by any means from my perspective. CEO has stated the this treatment in the past would cost patients $150,000. What if he only charges $50,000 per patient so that insurance companies get on board? At 20 patients per month, which is his goal for each clinic, that's phenomenal revenue for starters for just one clinic.
πŸ‘οΈ0
Jaguarjacket Jaguarjacket 1 day ago
Average Daily Volume Rising! $$$
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock